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A B S T R A C T
The aim of this study was to examine the characteristics of acute tonsillopharyngitis diagnosis and treatment in the
family care physicians in Mostar, Bosnia and Herzegovina. All patients diagnosed with acute tonsillopharyngitis in the
Center of Family Medicine in Mostar in 2005 and 2006 were included in this study. Data were collected from medical re-
cords, including age and sex, month in which they visited their physician, symptoms and signs that they had (McIsaac’s
clinical score was calculated accordingly) and treatment. Results showed that there were no gender differences regard-
ing diagnosis. Mean age was 32.6 ± 16.9 years. The most patients were recorded during the January-March period. Total
of 65.6% patients received antibiotic treatment. Phenoxymethylpenicillin, considered as the recommended antibiotic was
used in 46.3% cases only. In conclusion, this first critical assessment of the existing family practice records on treating
patients with tonsillopharyngitis suggested that physicians have to be more critical when treating patients with this di-
agnosis and that the knowledge and treatment of patients with pharyngitis need to be continuously improved in general
medical practice.
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Introduction
Acute tonsillopharyngitis is defined as an infection of
the pharynx and tonsils1. It is one of the most common
diseases associated with family physicians visits. Due to
its great prevalence and potential life-threatening com-
plications, it is considered as one of the important infec-
tious diseases in public health2. Although signs and symp-
toms of the disease are usually sufficient to make a
diagnosis, it is often difficult to make a distinction be-
tween bacterial and viral etiology on clinical grounds
alone3. Streptococcal infection is considered an appropri-
ate indication for antibiotic therapy and only 10% to 20%
of pharyngitis presentations in family practice are culture
positive for group A b-hemolytic streptococcus (GABHS)
whereas others are predominantly viral4–7. However, re-
ports from various countries estimate that antibiotics
are prescribed in 30% to 75% of visits. This suggests that
antibiotics are prescribed more often than necessary8–11.
Appropriate diagnosis of tonsillopharyngitis consists
of the epidemiologic setting, history, physical examina-
tion, rapid antigen tests and, in the case when the rapid
antigen tests are negative, a throat culture (as the gold
standard for diagnosing streptococcal infection) is used12.
But, in routine work, physicians often diagnose the acute
tonsillopharyngitis without any use of the laboratory
tests. In order to facilitate the diagnostic process, scoring
systems based on clinical symptoms and signs have been
developed6,13. However, none of the existing schemes
have been shown to reduce antibiotic prescribing in clini-
cal practice13. The major problem is not associated with
the choice of method, but the fact that physicians usually
fail to follow any guideline14. One of these score methods
was developed by Canadian physicians (McIsaac WJ et
al.) in the Family Medicine Centre at Mount Sinai Hospi-
tal, Toronto, Canada13,15. This score method has exten-
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ded practical use during routine work in general prac-
tice, as it is simple and it is also appropriate to children
as well as to the adults13.
As treatment of acute tonsillopharyngitis includes
symptomatic and etiologic (in this case only antibiotic)
treatment1, penicillin is recommended as first-line anti-
biotic against GABHS. The penicillin of choice is pheno-
xymethylpenicillin or oral penicillin V for 10 days. A sin-
gle intramuscular dose of benzathine penicillin G is the
first alternative. For individuals who are allergic to peni-
cillin, the drug of choice is erythromycin. Although peni-
cillin V is the drug of choice for bacterial pharyngitis,
physicians use it infrequently16. A study of Linder and
Stafford showed that physicians prescribed no recom-
mended antibiotics in 68% of visits and that use of no rec-
ommended, more expensive, broader-spectrum antibiot-
ics is frequent11. A possible reason is poor compliance
with the recommended 10-day courses16. The choice of
amoxicillin or amoxicillin with clavulanic acid, which are
active against most commonly occurring bacterial upper
respiratory tract pathogens, may also reflect an uncer-
tainty of the physicians about clinical diagnosis and the
etiology of infection16.
The aim of this study was to examine the characteris-
tics of acute tonsillopharyngitis diagnosis and treatment
among the population in care of family physicians in




This study was based on the secondary data, obtained
from the available medical records from the Center of
Family Medicine in Mostar. The Center is a family medi-
cine residency training site affiliated with the Mostar
University School of Medicine, with gravitation of ap-
proximately 10 000 patients from Mostar city area. Pa-
tients are mostly adults and elderly, while children usu-
ally have their own pediatrician. The Center employs 4
medical teams that handle over 12 000 primary care vis-
its annually.
Participants in this study were all patients with the
diagnosis of acute tonsillopharyngitis from January 2005
to December 2006. The data was collected only from
their medical records, without any contact with the pa-
tients. Several variables were collected and analyzed, in-
cluding age and sex of patients, month in which they vis-
ited their physician, symptoms and signs that they had
and according to them a clinical score was calculated, the
clinical score was analyzed and antibiotics as drugs of
choice were determined.
The clinical score method (McIsaac et al.) is based on
scoring clinical signs and symptoms13. Four characteris-
tics are associated with being more likely to have a throat
culture positive for GABHS: a temperature greater than
38 °C, absence of cough, tonsillar swelling and tender an-
terior cervical adenopathy. Each of these four clinical
findings are assigned a score of 1 point. To adjust for age,
children aged 3 to 14 years are assigned 1 point for their
higher prevalence of GABHS infection, those aged 15 to
44 receive a score of 0, and those aged 45 or more receive
a score of -1. If the score is +1 or less, neither a throat
swab nor antibiotic therapy is recommended. If the score
is +2 and +3, the recommendation is to obtain a throat
swab but wait for culture results before deciding about
antibiotic therapy, as in most cases the result would be
negative. And if the score is +4 or more, culture is re-
quired and therapy with penicillin could be started im-
mediately if the patient was in the early stage of the ill-
ness or was clinically unwell13.
Statistical analysis
All data were tested for normality of distribution with
the Kolmogorov-Smirnov test. Data were represented as
mean values and their standard errors. Chi-square test
was used for categorical variables analysis, while Ed-
wards test was used for seasonal pattern analysis. P val-
ues less than 0.05 were considered statistically significant.
SPSS Version 13.0 for Windows (SPSS Inc., Chicago, IL,
USA) and Microsoft Excel 11 (Microsoft Corporation,
Redmond, WA, USA) were used in analysis.
Results
During 2005 and 2006, a total of 244 patients diag-
nosed with acute tonsillopharyngitis were included in
the present study, 120 (49.2%) men and 124 (50.8%)










































Fig. 1. Age distribution of patients with acute tonsillopharyngitis
















Month (of the year)
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Fig. 2. Seasonal distribution of patient visit to the Center
of Family Medicine in Mostar, 2005–2006.
women (c2=0.066; P=0.798). Mean age was 32.6 ± 16.9
years (Figure 1), 31.8 ± 17.1 for men and 33.4 ± 16.7 for
women (t=0.714; P=0.476). The greatest number of pa-
tients was during the first three months of the year, that
confirmed that pharyngitis was usually highly prevalent
during the cold months of the year (Edwards P<0.0001,
peak date February 26th, with 65.8% of amplitude varia-
tion) (Figure 2). Number of patients with a score of +1
was predominant while the number of patients with a
score of –1 was the smallest (c2=57.820; P<0.001). Table
1 shows the distribution of patients by clinical score
value. Type of treatment was significantly different de-
pending on the score value (c2=57.978; P<0.001; Fisher’s
exact test) (Table 1). The most prescribed antibiotic was
phenoxymethylpenicillin or penicillin V (c2=275.875; P<
0.001) in 46.3% cases (Table 2).
Discussion
The results of our study confirmed that acute tonsillo-
pharyngitis was a very common infection among patients
consulting their family physicians. There was no signifi-
cant difference in age and sex among our patients regard-
ing the diagnosis. Mean age was 32.6 ± 16.9 years which
showed that infection occurred most frequently in youn-
ger adults, although this diagnosis is commonly expected
mostly in children and adolescents. This results could,
however, be the consequence of the lacking information
from the adolescent data, as family physicians usually do
not provide medical care for them. Furthermore, based
on the clinical score and the results of this study we can
conclude that our physicians overdiagnose bacterial pha-
ryngitis. Usually, 65.6% of pharyngitis cases are treated
with antibiotic, which is in accordance with results of
other studies8–11 that confirmed great antibiotic abuse
when treating this infection. Therefore, the conclusion is
that physicians should differentiate bacterial and viral
infections by using the clinical score method. The pro-
portion of patients receiving initial antibiotic prescrip-
tions should be reduced. Although phenoxymethylpe-
nicillin (penicillin V) is the drug of choice for bacterial
pharyngitis, physicians from this study used it insuffi-
ciently. It was most commonly prescribed antibiotic and
was used in 46.3% cases. Therefore, physicians should be
encouraged to prescribe antibiotics of first choice. Our
results and conclusions are similar to those found in pre-
vious studies11,13,16.
Limitations of this study include already mentioned
lack of school children. Also, family physicians often do
not take a throat swab because of objective reasons and
their diagnosis is based only on signs and symptoms. As a
result we couldn’t determine the real number of bacte-
rial pharyngitis cases without a throat culture. A recent
international study showed that clinical manifestation of
pharyngitis may vary with the region and it is therefore
critical that clinical decision rules for the treatment have
the local validation17. The McISaac scores are not the
gold standard for prescribing antibiotics and this score
has not been validated in patients from this region which
are another limits of the study.
Based on the findings and limitations of this study, we
can conclude that further research, especially among
school children, validation of the score method with spe-
cial remarks on the local population characteristics, and
lastly, education of physicians on the importance, clinical
symptoms and diagnosis of patients with acute tonsillo-
pharyngitis are needed.
The first critical assessment of the existing family prac-
tice when treating patients with tonsillopharyngitis war-
ned us to be more critical with this infection and that
knowledge and treatment of patients with pharyngitis needs
to be improved continuously in general practice in Mostar.
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TABLE 1
DISTRIBUTION OF PATIENTS WITH ACUTE
TONSILLOPHARYNGITIS AND TREATMENT TYPE IN PATIENTS
WITH ACUTE TONSILLOPHARYNGITIS TREATED WITH IN THE











–1 3 (42.9%) 4 (57.1%) 7 (2.9)
0 31 (51.7%) 29 (48.3%) 60 (24.6)
+1 33 (48.5%) 35 (51.5%) 68 (27.9)
+2 16 (39.0%) 25 (61.0%) 41 (16.8)
+3 1 (2.8%) 35 (97.2%) 36 (14.8)
+4 0 (0.0%) 32 (100.0%) 32 (13.0)
Total 84 (34.4%) 160 (65.6%) 244 (100.0)
TABLE 2
ANTIBIOTIC OF CHOICE IN ANTIBIOTIC TREATMENT OF PA-
TIENTS TREATED IN THE CENTER OF FAMILY MEDICINE IN
MOSTAR, 2005 – 2006
The first choice antibiotic No. (%)
Phenoxymethylpenicillin (penicillin V) 74 (46.2)
Amoxicillin 27 (16.8)
Ampicilin 4 (2.5)
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AKUTNI TONZILOFARINGITIS U OBITELJSKOJ MEDICINI U MOSTARU, BOSNA I HERCEGOVINA
S A @ E T A K
Cilj ove studije bio je ispitati osobitosti dijagnosticiranja i lije~enja akutnog tonzilofaringitisa u obiteljskoj medicini u
Mostaru, Bosna i Hercegovina. U studiju su bili uklju~eni svi pacijenti kojima je dijagnosticiran akutni tonzilofaringitis
u Centru za obiteljsku medicinu u Mostaru tijekom 2005 i 2006 godine. Svi podaci su prikupljani iz kartona pacijenata,
a uklju~ivali su: spol, dob, mjesec u kojem su se javili svom lije~niku, simptome i znakove koje su pacijenti imali (na
temelju ~ega je izra~unata McIsaac-ova klini~ka metoda zbroja) i na~in lije~enja. Rezultati su pokazali da nije bilo
zna~ajne razlike u spolu. Prosje~na dob oboljelih je bila 32,6 ± 16,9 god. Najvi{e oboljelih je bilo izme|u sije~nja i o`ujka.
65,6% pacijenata je primilo antibiotik. Antibiotik prvog izbora, fenoksimetilpenicilin, bio je popisan u samo 46,3% slu-
~ajeva. Zaklju~no, na{a prva kriti~ka prosudba postoje}e prakse u obiteljskoj medicini je pokazala da bi lije~nici trebali
kriti~nije prilaziti ovom problemu te da znanje i lije~enje pacijenata sa tonzilofaringitisom treba biti neprekidno pobolj-
{avano.
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